Patents by Inventor Theresa L. Whiteside

Theresa L. Whiteside has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS FOR STIMULATING EXOSOME SECRETION
    Publication number: 20220280460
    Abstract: Disclosed herein are methods for improving exosome production or stimulating exosome secretion by cells. The methods comprise inhibiting at least one step of the glycolytic pathway by contacting the cells with at least one glycolytic inhibitor and/or inhibiting mitochondrial function by contacting the cells with at least one inhibitor of mitochondrial function.
    Type: Application
    Filed: August 7, 2020
    Publication date: September 8, 2022
    Inventors: Edwin Kerry JACKSON, Theresa L. WHITESIDE, Nils LUDWIG
  • TUMOR CELL-DERIVED EXOSOMES AND THEIR APPLICATIONS
    Publication number: 20220229059
    Abstract: The disclosure features compositions and methods that may be used to detect the presence of tumor cell-derived exosomes in a patient (e.g., a human patient) having cancer. The compositions and methods described herein may also be used to evaluate the patient's prognosis, as well as monitor the likelihood of the patient to benefit from therapy, such as immunotherapy. The disclosure also features antibodies that specifically bind chondroitin sulphate proteoglycan 4 (CSPG4), as well as antigen-antibody complexes containing the same.
    Type: Application
    Filed: June 3, 2020
    Publication date: July 21, 2022
    Inventors: Soldano FERRONE, Theresa L. WHITESIDE
  • Method of increasing immunological effect
    Patent number: 8591956
    Abstract: A method of increasing immunological effect in a patient by administering an effective amount of a primary cell derived biologic to the patient, inducing immune production, blocking immune destruction, and increasing immunological effect in the patient. Methods of treating an immune target, treating a tumor, immune prophylaxis, and preventing tumor escape.
    Type: Grant
    Filed: August 8, 2011
    Date of Patent: November 26, 2013
    Assignee: IRX Therapeutics, Inc.
    Inventors: John W. Hadden, Theresa L. Whiteside-Nimick, James E. Egan, Kathy L. Signorelli-Petrat, Harvey Brandwein
  • METHOD OF INCREASING IMMUNOLOGICAL EFFECT
    Publication number: 20120141512
    Abstract: A method of increasing immunological effect in a patient by administering an effective amount of a primary cell derived biologic to the patient, inducing immune production, blocking immune destruction, and increasing immunological effect in the patient. Methods of treating an immune target, treating a tumor, immune prophylaxis, and preventing tumor escape.
    Type: Application
    Filed: August 8, 2011
    Publication date: June 7, 2012
    Inventors: John W. Hadden, Theresa L. Whiteside, Margareta Czytowska, James E. Egan, Kathy L. Signorelli, Harvey Brandwein
  • Method of increasing immunological effect
    Patent number: 7993660
    Abstract: A method of increasing immunological effect in a patient by administering an effective amount of a primary cell derived biologic to the patient, inducing immune production, blocking immune destruction, and increasing immunological effect in the patient. Methods of treating an immune target, treating a tumor, immune prophylaxis, and preventing tumor escape.
    Type: Grant
    Filed: November 26, 2008
    Date of Patent: August 9, 2011
    Assignee: IRx Therapeutics, Inc.
    Inventors: John W. Hadden, Theresa L. Whiteside, Margareta Czystowska, James E. Egan, Kathy L. Signorelli, Harvey Brandwein
  • METHOD OF INCREASING IMMUNOLOGICAL EFFECT
    Publication number: 20090155291
    Abstract: A method of increasing immunological effect in a patient by administering an effective amount of a primary cell derived biologic to the patient, inducing immune production, blocking immune destruction, and increasing immunological effect in the patient. Methods of treating an immune target, treating a tumor, immune prophylaxis, and preventing tumor escape.
    Type: Application
    Filed: November 26, 2008
    Publication date: June 18, 2009
    Inventors: John W. Hadden, Theresa L. Whiteside, Margareta Czystowska, James E. Egan, Kathy L. Signorelli, Harvey Brandwein